Another study found that fibrinogen to pre-albumin ratio was gradually increased alongside with the development of AFP-negative HCC and positively correlated with tumor size and Barcelona Clinic Liver Cancer stages (BCLC) [18]. The gene discussed is ALB; the disease is hepatocellular carcinoma.